COSCIENS Biopharma Inc. (CSCIF) Capital expenditures 2016–2025
COSCIENS Biopharma Inc. (CSCIF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$706,000FY2025 · since FY2016: $66,000 → $706,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $706,000 | -39.2% |
| FY2024 | $1.2M | +60.8% |
| FY2023 | $722,000 | +137.5% |
| FY2022 | $304,000 | +913.3% |
| FY2021 | $30,000 | — |
| FY2018 | $9,000 | +125.0% |
| FY2017 | $4,000 | -93.9% |
| FY2016 | $66,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice